|

DB107-FC Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: 5-fluorocytosine, Ancobon, Ancotil, Extended-release 5-fluorocytosine, Toca FC

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • University of California, San Francisco1
  • Ashish Shah1

Indications

  • High Grade Glioma2
  • Cancer2
  • MGMT-Methylated Glioblastoma1
  • MGMT-Unmethylated Glioblastoma1
  • Anaplastic Astrocytoma1

Los Angeles, California1 trial

DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma

University of Southern California

Phase 1/2

Miami, Florida1 trial

DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma

University of Miami Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.